Regulation of Amyloidogenic Secretases During Apoptosis

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005015
Summary
Evidence is accumulating that stroke significantly increases the risk of AD representing either a precipitating or a triggering event. Extensive studies have shown that stroke or head trauma results in neuronal cell death by the activation of a cell death program termed apoptosis. Apoptosis is characterized by the activation of a family of protease called caspases. The pharmacological inhibition of caspases has been shown to reduce cell death. Dr. Tanzi’s findings indicate that treatment of stroke and head trauma with caspase inhibitors might be useful not only to prevent neuronal cell death as a consequence of the acute events, but also to prevent the increase in Aβ production that contributes to AD pathogenesis. Dr. Tanzi’s proposed experiments should not only increase our understanding of the regulation of the amyloidogenic secretases, but suggest novel therapeutic strategies for treating and preventing AD.
Related Grants
Alzheimer's Disease Research
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
Amyloid Precursor Protein Processing Through a Novel Pathway in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Justyna Dobrowolska Zakaria, PhD
Current Organization
Northwestern University
Alzheimer's Disease Research
Exploring the Origin and Composition of a Unique Pathology in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Cyril Pottier, PhD
Current Organization
Washington University in St.Louis